Elevation Wealth Partners’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$312K Buy
2,146
+88
+4% +$12.9K 0.09% 114
2026
Q2
$302K Buy
2,058
+366
+22% +$53.3K 0.09% 109
2026
Q1
$244K Buy
1,692
+16
+1% +$2.43K 0.09% 104
2025
Q4
$240K Sell
1,676
-307
-15% -$45.3K 0.09% 107
2025
Q3
$305K Sell
1,983
-109
-5% -$17K 0.11% 99
2025
Q2
$333K Hold
2,092
– – 0.13% 89
2025
Q1
$357K Hold
2,092
– – 0.15% 78
2024
Q4
$351K Hold
2,092
– – 0.15% 79
2024
Q3
$362K Buy
2,092
+1
+0% +$170 0.16% 79
2024
Q2
$345K Sell
2,091
-73
-3% -$11.9K 0.16% 77
2024
Q1
$351K Sell
2,164
-807
-27% -$127K 0.18% 79
2023
Q4
$433K Buy
2,971
+2,546
+599% +$377K 0.26% 67
2023
Q3
$62K Buy
425
+2
+0.5% +$305 0.05% 134
2023
Q2
$64.2K Buy
423
+2
+0.5% +$301 0.05% 136
2023
Q1
$62.7K Buy
+421
New +$60.2K 0.06% 135

Other funds holding PG

Elevation Wealth Partners's PG Position: Q3 2026 in Review

Elevation Wealth Partners increased its Procter & Gamble (PG) stake by 4.3% in Q3 2026, buying an estimated $12.9K and bringing the position to 2,146 shares worth $312K. The position accounts for 0.09% of the portfolio, ranked #114.

Elevation Wealth Partners first reported a position in PG in Q1 2023 and has held it in 15 quarters since. The position peaked at $433K in Q4 2023. 1,528 funds tracked by Wall St. Rank hold PG as of Q3 2026.

  • Elevation Wealth Partners held 2,146 shares of Procter & Gamble worth $312K as of Q3 2026.
  • Elevation Wealth Partners bought 88 Procter & Gamble shares in Q3 2026, an estimated $12.9K.
  • Procter & Gamble made up 0.09% of Elevation Wealth Partners's portfolio in Q3 2026, its #114 holding.
  • Elevation Wealth Partners first reported a position in Procter & Gamble in Q1 2023 and has held it in 15 quarters since.
  • Elevation Wealth Partners's Procter & Gamble position peaked at $433K in Q4 2023.
  • 1,528 funds tracked by Wall St. Rank held Procter & Gamble as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.